We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Antibiotics for Diarrhea Increase Risk of Superbug Colonization

By HospiMedica International staff writers
Posted on 01 Feb 2015
A new study warns that treating travelers' diarrhea (TD) with antibiotics turns them into unknowing carriers of drug-resistant bacteria, and may even contribute to the spreading of these superbugs in their native countries.

Researchers at Helsinki University Hospital (Finland) collected stool samples from 430 Finns before and after traveling outside of Scandinavia. More...
All the specimens were analyzed for Extended-Spectrum Betalactamase-Producing Enterobacteriaceae (ESBL, an enzyme that shields the superbugs against common antibiotics) and carbapenemase-producing Enterobacteriaceae (CPE). Questionnaires were used to survey the participants about use of antimicrobials during their trip, as well as other potential risk factors.

The results revealed that 21% of the travelers had become colonized by ESBL-PE, but none by CPE. Geographic region, occurrence of TD, age, and use of antibiotics were identified as independent risk factors predisposing to contracting ESBL-PE, with nearly 40% of the travelers colonized with ESBL-producing bacteria. However, those who took antibiotics for TD while visiting South-Asian countries, such as India, Bangladesh, and Pakistan, faced the highest risk, with nearly 80% colonized by ESBL-PE. The study was published on January 21, 2015, in Clinical Infectious Diseases.

“The great majority of all cases of travelers’ diarrhea are mild and resolve on their own,” concluded lead author, Professor of Epidemics, Anu Kantele, MD, and colleagues. “In modern pre-travel counseling for those visiting high-risk regions, travelers should be advised against taking antibiotics for mild or moderate travelers' diarrhea.”

TD affects 20%–50% of international travelers (an estimated 10 million persons annually), with the primary source being ingestion of unhygienic, fecally contaminated food or water. The onset of TD usually occurs within the first week of travel but may occur at any time while traveling, and even after returning home. The most important determinant of risk is the traveler's destination; high-risk destinations are the developing countries of Latin America, Africa, the Middle East, and Asia. Persons at particular high-risk include young adults, the immunosuppressed, people with inflammatory-bowel disease or diabetes, and those taking H-2 blockers or antacids.

Related Links:

Helsinki University Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.